chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tiredness in leg; in a wheelchair after second dose of vaccine; Swelling; Heart racing; Out of breath; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Tiredness in leg) and GAIT DISTURBANCE (in a wheelchair after second dose of vaccine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction (no reported medical history).    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced MUSCULAR WEAKNESS (Tiredness in leg) (seriousness criterion disability), GAIT DISTURBANCE (in a wheelchair after second dose of vaccine) (seriousness criterion disability), SWELLING (Swelling), PALPITATIONS (Heart racing) and DYSPNOEA (Out of breath). At the time of the report, MUSCULAR WEAKNESS (Tiredness in leg), GAIT DISTURBANCE (in a wheelchair after second dose of vaccine), SWELLING (Swelling), PALPITATIONS (Heart racing) and DYSPNOEA (Out of breath) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No relevant concomitant medications were reported. The patient was treated with prednisone and Percocet (oxycodone/paracetamol).; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 45-year-old female patient who received FLULAVAL QUADRIVALENT. On 13th September 2016, the patient received FLULAVAL QUADRIVALENT (intramuscular). On an unknown date, less than a week after receiving FLULAVAL QUADRIVALENT, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to FLULAVAL QUADRIVALENT. Additional details were reported as follows: The patient was the employee. The patient experienced a grade 1 injection site pain reaction. The patient declined to provide date of birth. Due to time constraints, the patient had to end call prior to asking seriousness criteria questions. The patient could be contacted at later time for further information.
Usual post vaccine fever / resolved by 10/9/22      10/12/ 22.    Developed sore throat , headache and fever Covid ( PCR ) negative  10/18/22.      Developed intermittent dry cough and laryngitis  10/ 22/ 22.    Developed SOB , seen at urgent care , CXR showed pneumonia
about 1 wk p/shot arm kept hurting, went to wrists & hands into the fingers, its hard to bend fingers & they feel swollen, now in both arms, wrists & fingers; also ankles been aching for about wk; c/o itching;
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a adult female patient who received SHINGRIX. Concurrent medical conditions included anxiety (Diagnosed years before the reporting date) and migraine (Diagnosed prior to taking SHINGRIX). Concomitant products included PAXIL CR, TOPAMAX and XANAX. On an unknown date, the patient received SHINGRIX .5 ml. In February 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema and general body pain. In February 2018, the outcome of the general body pain was recovered/resolved. On an unknown date, the outcome of the injection site erythema was recovering/resolving. The reporter considered the injection site erythema and general body pain to be almost certainly related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received the SHINGRIX vaccine on Saturday in her right arm. The had general body aches for day or so after receiving SHINGRIX. The aching had stopped, but the paitnet stated that there was still a red spot there, but it appeared to be getting better. The patient had denied persission to contact their physician.
Case number PHHY2013US129294, is an initial report received from a consumer via the Vaccine Adverse Event Reporting System (VAERS reference number: 500785) website on 11 Nov 2013. This report refers to 45-year-old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with FLUVIRIN (batch number: not reported) on an unspecified date in 2011. On an unspecified date, she experienced nerve pain in the left arm. The reaction took about six months to get better. The seriousness and causality were not reported. On 26 Dec 2012, she was vaccinated with FLUVIRIN (batch number: not reported) and experienced pain in left arm and left hip on the hip bone (see case number: PHHY2013US127886).
Approximately 4 hours after injection I got a weird hot/cold sensation in my lower neck/between shoulder blades, felt chills throughout my body, was dizzy/off balance and nauseous for about half an hour
A week or so after getting the shot, my blood pressure started moving all over the board.  I went to Cardiologist and PCP to try  to find the cause.  All tests were good result.  Blood pressure would be real high one day and normal the next.  Numerous times considered ER visit.  After about 4 months BP is back to normal and feel fine.  There were no other mitigating factors that i can think of that would have caused this.  I cannot say it is due to the vaccine but it seems odd that it happened in the months after and then went back to normal with no changes to medication or lifestyle.
waking up with a crick in neck first 3 days. Both neck glands feel swollen. All muscles ache while in use.
Rash post nasal drip with sore throat. reports woke morning after injection with localized tenderness and rash (red, blotchy non-raised, skin intact, no sloughing, no pustules, etc.) in area surrounding the injection site. She also reports post nasal drip with sore throat, which she often gets with flu shots. She reports rash was slightly larger today (measured 4.5 x 4.5 cm) so she came to clinic.
9-17-20 Seen by physician for evaluation left upper arm: there is large area of swelling and erythema on the outer deltoid area in location of immunization. slightly warm to touch but not significant, no palpable lymph nodes at this time. full ROM of arm Received tdap on 9-10-20 left deltoid. Yesterday on 9-16-20  woke up with rash and redness at injection site. Today redness is larger and warm to touch.  she is likely reacting to something in the Adacel shot, will give her prednisone as below for 5 days use ibuprofen for pain and Benadryl for itching
Presented to the office on 11/14/06 with multiple erythematous papules all over his body. Approximately 25 lesions. Rash had been present for several days. No fever or any other symptoms.
Information has been received from a pharmacist referring to a 51 year old male patient with hypertension and unspecified cardiac problems. The patient's past medical history included lymphoma. Information about drug reactions or allergies was unspecified. On 07-NNOV-2015, the patient was vaccinated with ZOSTAVAX, 19400 PFU (lot number, dose and route were unknown) for shingles prevention. Concomitant medications were unspecified. On an unknown date in November 2015, the patient developed enlarged lymph nodes under the arm and he could not move his arm. The patient sought medical attention via contacting the pharmacist. The outcome of the events was reported as not recovered/not resolved. The causality between the events and ZOSTAVAX was unspecified. Additional information has been requested.
Within 6 hours erythematous area measuring about 2 cm in diameter was noticed on left arm at injection site. 24 hours later the erythema now measured 7 cm, area was hot to the touch and very swollen, non tender. Condition persisted for another 24 hours before, subsiding.
CLIENT NOTED FINE RASH APPEARING ON BOTH UPPER ARMS, WRISTS AND FEET, SLIGHT SWELLING OF BOTH PALMS OF THE HANDS AND FEELING OF DIZZINESS. VISITED HD C/O ABOVE S/S, FINE RASH NOTED AS DESCRIBED ABOVE. WAS SEEN BY CLINIC PHYSICIAN, INSTRUCTED TO TAKE AN ANTIHISTAMINE. IT WAS ALSO NOTED THAT CLIENT HAD SUSHI LAST NIGHT.
flu symptoms; severe headache; aches; chills; This spontaneous case was reported by a non-health professional and describes the occurrence of INFLUENZA (flu symptoms), HEADACHE (severe headache), MYALGIA (aches) and CHILLS (chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INFLUENZA (flu symptoms), HEADACHE (severe headache), MYALGIA (aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 27-Jan-2021, HEADACHE (severe headache) had resolved. At the time of the report, INFLUENZA (flu symptoms), MYALGIA (aches) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-295648 (Patient Link).
Lips tingled for aprox 30 mins. I do however have a small amount of lip filler.
pt woke up w/generalized rash that looked like hives;non noticed on face, hands  & feet;taken to MD who stated rash not r/t vax but probably caused from clothes;
On July 17, 2021 he developed a small fever blister on right side of  upper lip.   On July 19 noted to have weakness on Right side of mouth then on July 20,2021 he was diagnosed with Bell?s palsy at pcp office
Pregnant and received 1 dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant and received 1 dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant and received 1 dose). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant and received 1 dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product were reported.
Patient is under age. Patient's mother provided a false birthday on the consent form and in person to the Pharmacy. Called and confirmed with the mom that she knowingly provided false information to the Pharmacy.
This spontaneous case was reported by a physician and describes the occurrence of URINARY RETENTION (urinary retention), PETECHIAE (a little bit of petechia lesions on his legs & hands), DYSPNOEA (shortness of breath), LYMPHADENOPATHY (cervical lymph node adenopathy in his neck) and MYALGIA (body aches) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 036A21A and 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced LYMPHADENOPATHY (cervical lymph node adenopathy in his neck) and NAUSEA (nausea). On 04-Dec-2021, the patient experienced PYREXIA (mild fever / fever off & on). On 05-Dec-2021, the patient experienced URINARY RETENTION (urinary retention), PETECHIAE (a little bit of petechia lesions on his legs & hands), DYSPNOEA (shortness of breath), MYALGIA (body aches), FATIGUE (fatigue) and CHILLS (chills off & on). At the time of the report, URINARY RETENTION (urinary retention), PETECHIAE (a little bit of petechia lesions on his legs & hands), DYSPNOEA (shortness of breath), LYMPHADENOPATHY (cervical lymph node adenopathy in his neck), MYALGIA (body aches), FATIGUE (fatigue), CHILLS (chills off & on), PYREXIA (mild fever / fever off & on) and NAUSEA (nausea) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug details were reported. No treatment details were reported. This case was linked to MOD-2021-411004 (Patient Link).
Swollen lymph nodes in both side of neck, groin , chest and stomach.  After several chest Xrays , CT Scans and ultrasound I was diagnosed with lymphoma
Covid 19 , Pfizer vaccine:  resulted in  breakthrough bleeding daily while on birth control and still continuing .
Slight fever, significant body aches, chills, and nausea.  Like a bad flu.  Went to bed at 7pm.  Felt better the next morning.  ~12 hours
Received three doses of AVA from 4 Jun- 18 Jul 07 prior to deployment on 23 Jul 07. He did have an episode of bilateral leg edema around the time of his first vaccination; cannot be sure if it was just prior to or after vaccination. The edema persisted for 1-2 days and then subsided. He did not seek medical attention. During his trip overseas he had a recurrent episode of swelling that persisted. He sought medical attention on 13 Aug when it was noted he had elevated urine protein. During his workup it was noted that he had monoclonal gammopathy and by mid September he was diagnosed as having Multiple Myeloma. He denies family history and agricultural exposure. His first four years of service included working around diesel and jet fuels on the flight line.
Fever, severe chills, muscle and joint pain (severe), headache so severe it caused nausea. I was in bed, unable to do normal things. for two full days after this injection. Very large dark pink, raised rash around injection site on left bicep.
Chest pain; Dry cough; Phlegm; Fever; Fatigue; Sore throat; Stuffy nose; Her eyes looked like they were drooping; This case was reported by a consumer via call center representative and described the occurrence of sore throat in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th May 2022, the patient received the 1st dose of Bexsero (intramuscular) .5 µl and Bexsero Pre-Filled Syringe Device. On 6th May 2022, several hours after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced sore throat, nasal stuffiness and tired eyes. On 7th May 2022, the patient experienced chest pain, dry cough, phlegm, fever and fatigue. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the sore throat, nasal stuffiness, tired eyes, chest pain, dry cough, phlegm, fever and fatigue were unknown.   It was unknown if the reporter considered the sore throat, nasal stuffiness, tired eyes, chest pain, dry cough, phlegm, fever and fatigue to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-MAY-2022 Reporter's Comments: The patient's mother reported the case.  The patient received her dose of the Bexsero vaccine in the left arm. A few hours later she began to experience a sore throat, stuffy nose and her eyes looked like they were drooping.  The mother said that she gave her a Tylenol tablet and patient went to bed.  The next morning, she had chest pain, a dry cough, phlegm, fever, and fatigue.  The mother took her to the emergency room. The mother was told these were side effects of the Bexsero vaccine by the ER (emergency room) and she was told by pediatrician that there were no side effects to the Bexsero Vaccine when she gave it to her daughter.  The reporter disconnected the call abruptly before any further inquiry.  The reporter did not consent to follow up.
Itchy; "Looked like it had bee sting"; "Rashy"; "Super" red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING ("Looked like it had bee sting"), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH ("Rashy") and VACCINATION SITE ERYTHEMA ("Super" red) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010AZ(orL)IA) for COVID-19 vaccination.     The patient's past medical history included Celiac disease. Concurrent medical conditions included Gluten intolerance.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE SWELLING ("Looked like it had bee sting"), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH ("Rashy") and VACCINATION SITE ERYTHEMA ("Super" red). At the time of the report, VACCINATION SITE SWELLING ("Looked like it had bee sting"), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH ("Rashy") and VACCINATION SITE ERYTHEMA ("Super" red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment details not provided.
Pt. experienced vasovagal episode, turned pale for about 5-10 seconds.  Vitals were taken and blood pressure and SpO2 were normal before leaving clinic.  Mother states that he said he felt like he was "choking" after he left clinic, he is okay now.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In or around July 2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dosage, route of administration and anatomical location were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered shingles.As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations and seriousness of her condition. As a result of the zoster vaccine live (ZOSTAVAX), she sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, she suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of shingles was considered to be not recovered. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of shingles was determined to be disabling.
breathing difficult; Erythema; pyrexia; Chills; Bronchitis; Sweating; Redness on the arm and chest; Coughing,Cough Up Mucus; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and DYSPNOEA (breathing difficult) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Flu shot. Past adverse reactions to the above products included Bronchitis with Flu shot. Concurrent medical conditions included Chronic bronchitis, Asthma, Drug intolerance, Drug intolerance, Food allergy (Allergic to chocolate) and Egg allergy. Concomitant products included TRAMADOL for Back ache, VITAMIN D3 for Fatigue, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and EPLERENONE for Hypertension, OMEPRAZOLE for Ulcer and GERD.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Coughing,Cough Up Mucus). On 25-Feb-2021, the patient experienced BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and CHILLS (Chills). 25-Feb-2021, the patient experienced PYREXIA (pyrexia) and HYPERHIDROSIS (sweat). On an unknown date, the patient experienced DYSPNOEA (breathing difficult). At the time of the report, COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest), DYSPNOEA (breathing difficult), PYREXIA (pyrexia), HYPERHIDROSIS (sweat) and CHILLS (Chills) outcome was unknown.            concomitant medication including Iron supplement 65mg  for 2 to 3 week for anaemia and benadryl  50 mg at night for itching is being taken by patient Treatment information was not provided.   This case was linked to MOD-2021-036981 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Patient medical history includes Intolerant of NSAIDS and ACE inhibitors, Flu shot were added On 05-May-2021: Initial additional included non-significant patient information . On 22-Jul-2021: TCR included no new significant information. On 05-Aug-2021: Added batch number for dose 1 , and added chocolate and food allergies, added concomitant medications, added few events
No additional adverse event; Nurse reported that a patient received an expired VARVIVAX.; This spontaneous report was received from a nurse referring to a unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On 22-FEB-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #u004714, expiration date: 10-FEB-2023 (who had been verified to be a valid number and assessed as the same date reported) administered for prophylaxis (strength, dose, and route of administration were not provided) (expired product administered). No additional adverse event reported.
Positive for Covid; severe illness; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive for Covid) and ILLNESS (severe illness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Positive for Covid) and ILLNESS (severe illness). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive for Covid) and ILLNESS (severe illness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.